Hydralazine hydrochloride/Isosorbide Dinitrate

盐酸肼屈嗪/硝酸异山梨酯

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHydralazine hydrochloride/Isosorbide Dinitrate
Drug Alias NameIsosorbide Dinitrate/Hydralazine hydrochloride盐酸肼屈嗪硝酸异山梨酯硝酸异山梨酯/盐酸肼屈嗪Isosorbide Dinitrate and Hydralazine hydrochlorideHydralazine hydrochloride and Isosorbide Dinitrate +[9] 
ClassificationSmall molecules
Mechanisms of ActionAmine oxidase, copper containing inhibitorsAtrial natriuretic peptide receptor agonists
TargetsAmine oxidase, copper containingAtrial natriuretic peptide receptor
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2005/06/23
Country/TerritoryUnited States
CombinationsYes Hydralazine hydrochlorideIsosorbide Dinitrate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesArbor Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesArbor Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeC01DA58
Related LinksKEGG